Middle East & Africa Glioma Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)

No. of Pages: 92    |    Report Code: BMIRE00029269    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Glioma Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Glioma Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Glioma Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in Prevalence of High- Grade Glioma
  • 5.1.2 Increasing Various Initiatives Undertaken by the Regional and State Governments
5.2 Market Opportunities
  • 5.2.1 Increasing Opportunities in Emerging Economies
5.3 Future Trends
  • 5.3.1 Increasing Drug Approval for Glioma Treatment
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Glioma Treatment Market Regional Analysis

6.1 Middle East & Africa Glioma Treatment Market Overview
6.2 Middle East & Africa Glioma Treatment Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Glioma Treatment Market Forecast Analysis

7. Middle East & Africa Glioma Treatment Market Analysis – by Disease

7.1 Astrocytoma
  • 7.1.1 Overview
  • 7.1.2 Astrocytoma: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Oligoastrocytoma
  • 7.2.1 Overview
  • 7.2.2 Oligoastrocytoma: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oligodendroglioma
  • 7.3.1 Overview
  • 7.3.2 Oligodendroglioma: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Glioma Treatment Market Analysis – by Treatment Type

8.1 Surgery
  • 8.1.1 Overview
  • 8.1.2 Surgery: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Chemotherapy
  • 8.2.1 Overview
  • 8.2.2 Chemotherapy: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Radiation Therapy
  • 8.3.1 Overview
  • 8.3.2 Radiation Therapy: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Glioma Treatment Market Analysis – by Grade

9.1 Low Grade
  • 9.1.1 Overview
  • 9.1.2 Radiation Therapy: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 High Grade
  • 9.2.1 Overview
  • 9.2.2 Radiation Therapy: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Glioma Treatment Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Glioma Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Middle East & Africa Glioma Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Disease
    • 10.1.1.1.2 South Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Treatment Type
    • 10.1.1.1.3 South Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Grade
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Glioma Treatment Market Breakdown, by Disease
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Glioma Treatment Market Breakdown, by Treatment Type
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Glioma Treatment Market Breakdown, by Grade
  • 10.1.1.3 UAE: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Glioma Treatment Market Breakdown, by Disease
    • 10.1.1.3.2 UAE: Middle East & Africa Glioma Treatment Market Breakdown, by Treatment Type
    • 10.1.1.3.3 UAE: Middle East & Africa Glioma Treatment Market Breakdown, by Grade
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Disease
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Treatment Type
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Glioma Treatment Market Breakdown, by Grade

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Glioma Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Amgen Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Amneal Pharmaceuticals Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Biocon Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Karyopharm Therapeutics Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pfizer Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Sun Pharmaceutical Industries Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Teva Pharmaceutical Industries Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Middle East & Africa Glioma Treatment Market

1. Amgen Inc 
2. Amneal Pharmaceuticals Inc
3. Biocon Ltd
4. F. Hoffmann-La Roche Ltd
5. Karyopharm Therapeutics Inc
6. Merck & Co Inc
7. Pfizer Inc
8. Sun Pharmaceutical Industries Ltd
9. Teva Pharmaceutical Industries Ltd

middle-east-and-africa-glioma-treatment-market